QTAS is building a quantum-enabled liquid biopsy platform designed for pharma and translational research workflows
QTAS is building a quantum-enabled liquid biopsy platform designed for pharma and translational research workflows. Their technology enables automated isolation of rare circulating tumor cells directly from whole blood, unlocking rapid, high-quality downstream analysis such as sequencing, molecular profiling, and functional assays.